oasis 1 oral semaglutide 50 mg nejm 2023 obesity and Cardiovascular Outcomes in without Diabetes New NEJM Trials: Oral GLP-1

Astaxanthin + L Glutathione + Lutein may be indicated by your doctor for: Supportive use to help maintain retinal and visual function in individuals experiencing visual strain, eye fatigue, or age-related changes in vision

In rare cases, glutathione supplementation can cause unpleasant side effects

Plasma concentrations and dietary intakes of choline and betaine in association with atrial fibrillation risk: results from 3 prospective cohorts with different health profiles

By sharing outcomes, questioning what we've always done, and truly listening to our patients and providers, we can make these programs even better

Always consult your healthcare provider before making changes to your medication regimen, especially during illness